CYTOTOXIC SUBSTITUTED 2-(1 H-PYRAZOL-1 -YL)-1,3-BENZOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF CANCER

The present invention relates to substituted 2-(1lH-pyrazol-1-yl)-1,3-benzothiazole compounds of general formula (I) : in which R1, R2, R3, R4, R5, R6 and R7 are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutica...

Full description

Saved in:
Bibliographic Details
Main Authors STEIGEMANN, Patrick, GÜNTHER, Judith, THEDE, Kai, ZORN, Ludwig, SCHWEDE, Wolfgang, KOPPITZ, Marcus, ALGIRE, Carolyn, CHRISTIAN, Sven, GRÜNEWALD, Sylvia, NEUHAUS, Roland
Format Patent
LanguageEnglish
French
Published 22.12.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to substituted 2-(1lH-pyrazol-1-yl)-1,3-benzothiazole compounds of general formula (I) : in which R1, R2, R3, R4, R5, R6 and R7 are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients. La présente invention concerne des composés 2-(1H-pyrazol-1-yl)-1,3-benzothiazole substitués de formule générale (I) : dans laquelle R1, R2, R3, R4, R5, R6 et R7 sont tels que définis dans la description, des procédés de préparation desdits composés, des composés intermédiaires utiles pour préparer lesdits composés, des compositions et associations pharmaceutiques comprenant lesdits composés ainsi que l'utilisation desdits composés pour fabriquer une composition pharmaceutique destinée au traitement ou à la prophylaxie d'une maladie, en particulier des néoplasmes, comme agent seul ou en association avec d'autres principes actifs.
Bibliography:Application Number: WO2016EP63546